首頁 > 市場調查報告書 > 醫療設備

市場調查報告書

商品編碼

1510411

生育治療市場規模、佔有率和成長分析：按產品、按程序、按患者類型、按最終用戶、按地區 - 行業預測，2024-2031 年

Infertility Treatment Market Size, Share, Growth Analysis, By Product(Equipment, Microscopes ), By Procedure(Assisted Reproductive Technology ), By Patient Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年07月04日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年不孕症治療的市場規模預計為32億美元，預計將從2023年的34億美元成長到2031年的54.5億美元，預測期內（2024-2031年）複合年成長率為6.1% 。

由於不孕率上升、孕產婦年齡成長、生活方式的改變以及醫療技術的進步等多種因素，不孕症治療市場最近經歷了顯著成長。不孕症影響著世界上很大一部分人口，推動了對有效和創新治療方案的需求。輔助生殖技術（ART），例如體外受精（IVF）、卵細胞質內單一精蟲顯微注射術（ICSI）和相關手術，已成為面臨不孕症挑戰的夫婦的主流選擇。這些技術不斷改進，從而提高成功率並改善患者的治療效果。隨著這些技術變得更容易獲得和負擔得起，不孕症治療市場預計將進一步擴大。除了技術進步外，對第三方生育方法的接受度提高、可支配收入增加、延遲生育的趨勢等因素也在影響市場。

市場概況
輔助生殖技術（ART）
- 體外受精 IVF
- 卵細胞質內單一精蟲顯微注射術
- 代孕
人工授精
- 在子宮內
- 子宮頸內的
- 輸卵管內授精
節育手術
- 腹腔鏡檢查
- 子宮鏡檢查
- 子宮肌瘤切除術
- 開放性手術
- 輸卵管結紮松解術
- 靜脈曲張切除術
- 顯微外科重組
- 血管造口術
- 輸精管睪丸切開術
其他

生育治療市場：依患者類型

市場概況
女士
男性

生育治療市場：依最終用戶分類

市場概況
不孕不育診所
醫院
手術中心
冷凍庫
研究機構

生育治療市場：按地區

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Merck KGaA（Germany）
Bayer AG（Germany）
Ferring Pharmaceuticals（Switzerland）
CooperSurgical, Inc.（United States）
Cook Medical（United States）
Vitrolife AB（Sweden）
Irvine Scientific（United States）
Origio（Denmark）
Progyny, Inc.（United States）
OvaScience（United States）
Monash IVF（Australia）
Genea Limited（Australia）
Boston IVF（United States）
Cryo-Save AG（Switzerland）
Invo Bioscience（United States）
Reproductive Medicine Associates of New Jersey（United States）
Virtus Health（Australia）
LifeGlobal Group, LLC（United States）
Andrology Solutions（United States）
ProcreaTec（Spain）

簡介目錄

Product Code: SQMIG35D2204

Infertility Treatment Market size was valued at USD 3.2 Billion in 2022 and is poised to grow from USD 3.40 Billion in 2023 to USD 5.45 Billion by 2031, at a CAGR of 6.1% during the forecast period (2024-2031).

The infertility treatments market has seen significant growth recently due to various factors including rising infertility rates, increased maternal age, lifestyle changes, and advancements in medical technology. Infertility affects a substantial portion of the global population, driving the demand for effective and innovative treatment options. Assisted reproductive technology (ART), such as in vitro fertilization (IVF), intracytoplasmic sperm injection (ICSI), and related procedures, have become mainstream choices for couples facing infertility challenges. These technologies have undergone continuous improvements, leading to higher success rates and improved patient outcomes. The market for infertility treatments is expected to expand further as these technologies become more accessible and affordable. In addition to technological advancements, the market is influenced by factors like increasing acceptance of third-party reproduction methods, rising disposable incomes, and the trend of delaying parenthood.

Top-down and bottom-up approaches were used to estimate and validate the size of the Infertility Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Infertility Treatment Market Segmental Analysis

The global Infertility Treatment market is segmented based on product, patient type, procedure, end-user, and region. Based on Product, the market is segmented into Microscopes, Media & Consumables, Accessories which are which are further categorized. By Procedure, it is divided into Assisted Reproductive Technology (In Vitro Fertilization [Intracytoplasmic Morphologically Selected Sperm Injection, Gamete Donation], Intracytoplasmic Sperm Injection, Surrogacy), Artificial Insemination (Intrauterine, Intracervical, and Intratubal), Fertility Surgeries (Laparoscopy, Hysteroscopy, Myomectomy, Laparotomy, Tubal Ligation Reversal, Varicocelectomy, Microsurgical Reconstruction [Vasovasostomy, Vasoepididymostomy]), Others. Based on patient type, the market is segmented into Female Infertility Treatment, and Male Infertility Treatment. Based on End-User, it is segmented into Fertility Clinics, Hospitals, Surgical Centers, Research Institutes. Based on region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa.

Drivers of the Infertility Treatment Market

The rise in global infertility rates is attributed to factors such as lifestyle changes, delayed parenthood, and environmental influences. This increase in the number of individuals and couples experiencing fertility challenges has led to a heightened demand for infertility treatment options. Additionally, advancements in medical technology, particularly in assisted reproductive technologies such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), have significantly improved success rates, making these treatments more effective and accessible.

Restraints in the Infertility Treatment Market

One of the primary challenges in the market is the high cost associated with advanced infertility treatments like in vitro fertilization (IVF) and genetic screening. The significant financial burden of these procedures creates a substantial barrier to access for many people. Furthermore, ethical concerns related to assisted reproductive technologies, such as issues surrounding embryo manipulation and the ethical implications of surrogacy, introduce complexities that can hinder market growth.

Market Trends of the Infertility Treatment Market

Increasing consumer awareness and greater adoption of straightforward labeling products: There is a rising trend towards precision medicine approaches, particularly in in vitro fertilization (IVF). Genetic testing and screening technologies have become increasingly essential, enabling more targeted and personalized selection of embryos with higher chances of successful implantation, thereby reducing the risk of genetic disorders. Another significant trend involves the increasing acceptance and integration of third-party reproduction methods. Surrogacy, as well as egg or sperm donation, are gaining wider societal acceptance, offering alternative pathways to parenthood for individuals and couples experiencing infertility challenges.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Ecosystem of the Market
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Infertility Treatment Market by Product

Market Overview
Equipment
Microscopes
- Imaging Systems
- Sperm Analyzer Systems
- Ovum Aspiration Pumps
- Micromanipulator Systems
- Incubators
- Gas Analysers
- Laser Systems
- Cryosystems
- Sperm Separation Systems
Media & Consumables
Accessories

Infertility Treatment Market by Procedure

Market Overview
Assisted Reproductive Technology
- In Vitro Fertilization IVF
- Intracytoplasmic Sperm Injection
- Surrogacy
Artificial Insemination
- Intrauterine
- Intracervical
- Intratubal Insemination
Fertility Surgeries
- Laparoscopy
- Hysteroscopy
- Myomectomy
- Laparotomy
- Tubal Ligation Reversal
- Varicocelectomy
- Microsurgical Reconstruction
- Vasovasostomy
- Vasoepididymostomy
Others

Infertility Treatment Market by Patient Type

Market Overview
Female Infertility Treatment
Male Infertility Treatment

Infertility Treatment Market by End User

Market Overview
Fertility Clinics
Hospitals
Surgical Centres
Cryobanks
Research Institutes

Infertility Treatment Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ferring Pharmaceuticals (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CooperSurgical, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cook Medical (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vitrolife AB (Sweden)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Irvine Scientific (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origio (Denmark)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Progyny, Inc. (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OvaScience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Monash IVF (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genea Limited (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boston IVF (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cryo-Save AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Invo Bioscience (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Reproductive Medicine Associates of New Jersey (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virtus Health (Australia)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
LifeGlobal Group, LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Andrology Solutions (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ProcreaTec (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments